Planet 13 Holdings (PLNH) Shares Outstanding (Weighted Average) (2020 - 2026)
Planet 13 Holdings (PLNH) reported Shares Outstanding (Weighted Average) of $327.9 million for Q1 2026, up 0.82% year-over-year from $325.3 million in Q1 2025, and up 1648.92% quarter-over-quarter from $18.8 million in Q4 2025.
Planet 13 Holdings (PLNH) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $327.9 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $327.9 million, up 0.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $327.9 million (up 0.82% YoY), and the FY2025 annual result was $325.3 million, up 11.35% from the prior year.
- Shares Outstanding (Weighted Average) rose to $327.9 million in Q1 2026 per PLNH's latest filing, from $18.8 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $327.9 million in Q1 2026 and troughed at $5.2 million in Q4 2022.
- A 5-year average of $215.4 million and a median of $225.1 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) slumped 41.25% in 2022, then surged 42.39% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $5.2 million in 2022, then soared by 4158.4% to $221.7 million in 2023, then slumped by 91.54% to $18.8 million in 2024, then changed by 0.0% to $18.8 million in 2025, then surged by 1648.92% to $327.9 million in 2026.
- Business Quant data shows PLNH's Shares Outstanding (Weighted Average) at $327.9 million in Q1 2026, $18.8 million in Q4 2025, and $325.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 100.50 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 5.11 Bn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 88.01 Mn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn | 327.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 327.92 Mn |
| Dec 31, 2025 | 18.75 Mn |
| Sep 30, 2025 | 325.36 Mn |
| Jun 30, 2025 | 325.31 Mn |
| Mar 31, 2025 | 325.26 Mn |
| Dec 31, 2024 | 18.75 Mn |
| Sep 30, 2024 | 281.09 Mn |
| Jun 30, 2024 | 289.18 Mn |
| Mar 31, 2024 | 228.44 Mn |
| Sep 30, 2023 | 221.71 Mn |
| Jun 30, 2023 | 221.44 Mn |
| Mar 31, 2023 | 221.08 Mn |
| Dec 31, 2022 | 5.21 Mn |
| Mar 31, 2022 | 205.57 Mn |
| Dec 31, 2021 | 8.86 Mn |
| Sep 30, 2021 | 196.29 Mn |
| Jun 30, 2021 | 196.29 Mn |
| Mar 31, 2021 | 190.78 Mn |
| Dec 31, 2020 | 7.16 Mn |